DAVITA HEALTHCARE PARTNERS INC. 4

Accession 0001179110-16-027311

$DVACIK 0000927066operating

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 3:07 PM ET

Size

24.1 KB

Accession

0001179110-16-027311

Insider Transaction Report

Form 4

Period: 2016-07-01

DAVITA HEALTHCARE PARTNERS INC.DVA

JIGANTI JEANINE MARIE

Chief Compliance Officer

Transactions

Tax Payment
Common Stock
2016-07-01$77.32/sh−5,157$398,739→ 7,121 total
Sale
Common Stock
2016-07-01$77.50/sh−1,236$95,792→ 4,778 total
Exercise/Conversion
Stock Appreciation Rights
2016-07-01−7,500→ 7,500 total
Exercise: $53.16From: 2015-12-05Exp: 2017-12-05→ Common Stock (7,500 underlying)
Exercise/Conversion
Common Stock
2016-07-01$48.68/sh+2,812$136,888→ 7,590 total
Sale
Common Stock
2016-07-01$77.38/sh−1,041$80,554→ 4,778 total
Sale
Common Stock
2016-07-01$77.46/sh−2,343$181,489→ 4,778 total
Exercise/Conversion
Common Stock
2016-07-01$58.94/sh+5,200$306,488→ 9,978 total
Tax Payment
Common Stock
2016-07-01$77.32/sh−3,964$306,496→ 6,014 total
Exercise/Conversion
Stock Appreciation Rights
2016-07-01−2,812→ 938 total
Exercise: $48.68From: 2013-07-09Exp: 2017-07-09→ Common Stock (2,812 underlying)
Exercise/Conversion
Stock Appreciation Rights
2016-07-01−5,200→ 5,200 total
Exercise: $58.94From: 2016-03-19Exp: 2018-03-19→ Common Stock (5,200 underlying)
Tax Payment
Common Stock
2016-07-01$77.32/sh−1,771$136,934→ 5,819 total
Exercise/Conversion
Common Stock
2016-07-01$53.16/sh+7,500$398,700→ 12,278 total

Footnotes (7)

[F1]The exercises and sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2016.
[F2]Represents the weighted average sale price of $77.3810. The range of prices for the sale of these shares was $77.36 - $77.40, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F3]Represents the weighted average sale price of $77.4599. The range of prices for the sale of these shares was $77.40 - $77.50, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F4]Represents the weighted average sale price of $77.5016. The range of prices for the sale of these shares was $77.50 - $77.52, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number shares sold at each separate price.
[F5]The Stock Appreciation Rights were granted on 7/9/2012. 25% vested on 7/9/2013, then 6.25% vested every three months thereafter.
[F6]The Stock Appreciation Rights were granted on 12/5/2012. 50% vested on 12/5/2015 and the remaining 50% will vest on 12/5/2016.
[F7]The Stock Appreciation Rights were granted on 3/19/2013. 50% vested on 3/19/2016 and the remaining 50% will vest on 3/19/2017.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

DAVITA HEALTHCARE PARTNERS INC.

CIK 0000927066

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000927066

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 3:07 PM ET
Size: 24.1 KB

View on SEC.gov